We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
What Are the Data Behind ATT?
Which Amyloid-Targeting Therapy is Best?
What’s the Best Way to Identify Mild Cognitive Impairment and Early Alzheimer’s Disease?
What is the Role of APOE4 Testing in Alzheimer’s Disease?
Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?
How Much Should We Worry About Amyloid-Related Imaging Abnormalities?
How Do You Counsel Patients About Amyloid-Related Imaging Abnormalities?
How Should We Monitor Patients on Amyloid-Targeting Therapy?
What Does ARIA Look Like Clinically?
What Types of Changes, If Any, Should We Expect with Amyloid-Targeting Therapy?
Do Women Respond Differently to ATT Than Men?
Is Amyloid-Targeting Therapy Worth It?
Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations – and the Critical Role of Shared Decision-Making in Its Use
Clete A. Kushida, MD, PhD
Michael J. Thorpy, MD
Pediatric Narcolepsy: Addressing the Challenges in Its Recognition, Diagnosis, and Management
Anne Marie Morse, DO
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education